As the underlying<unk>  microdeletion is an innate genetic disorder, it cannot by itself be treated. Rather, treatment is symptomatic and supportive. The high prevalence of kidney disease indicates routine monitoring of renal function, particularly in people taking potentially nephrotoxic medications such as lithium. The comorbities involved in<unk>  require caution in medical treatment; for instance, the increased risk of diabetes requires strict monitoring for post-transplantation diabetes mellitus in kidney transplant patients, as does the risk of weight gain and diabetes from neuroleptic drugs in those with a mental health diagnosis.
17q12 microdeletion syndrome
13q deletion syndrome
2q37 deletion syndrome
22q13 deletion syndrome
1p36 deletion syndrome
22q11.2 distal deletion syndrome
3q29 microdeletion syndrome
1q21.1 deletion syndrome